Insider · CIK 0001733680

Bruck Claudine

Reports to the SEC for 2 companies · MALVERN, PA

sec.gov

Transactions

Companies

Filings

CIK

0001733680

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-09-10	ANVSAnnovis Bio, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7,142 sh	$0.14	+$999.88	13,709
2025-09-10	ANVSAnnovis Bio, Inc. · OptionM Exercise/Conversion	Director	MExercise/Conversion	−7,142 sh	—	—	0
2023-11-20	ANVSAnnovis Bio, Inc.J Other	Director	JOther	0 sh	—	—	6,567
2023-11-20	ANVSAnnovis Bio, Inc.A Award	Director	AAward	+1,000 sh	$6.07	+$6,070	7,567
2023-11-17	ANVSAnnovis Bio, Inc. · Stock Option (right to buy)A Award	Director	AAward	+26.2K sh	—	—	26,200
2023-04-07	ANVSAnnovis Bio, Inc.A Award	Director	AAward	+500 sh	$12.61	+$6,305	6,567
2023-01-18	ANVSAnnovis Bio, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,967 sh	—	—	5,967
2022-01-03	ANVSAnnovis Bio, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2021-10-11	ANVSAnnovis Bio, Inc.P Purchase	Director	PPurchase	+181 sh	$27.66	+$5,006.46	6,067
2021-07-07	ANVSAnnovis Bio, Inc. · Stock Option (right to buy)A Award	Director	AAward	+4,000 sh	—	—	4,000
2021-06-30	NAVIDEA BIOPHARMACEUTICALS, INC.A Award	Director	AAward	+3,969 sh	—	—	16,519
2021-01-13	NAVIDEA BIOPHARMACEUTICALS, INC.Stock OptionA Award	Director	AAward	+2,500 sh	$0.00	+$2.5	2,500
2021-01-13	NAVIDEA BIOPHARMACEUTICALS, INC.A Award	Director	AAward	+2,500 sh	$0.00	+$2.5	12,550
2020-07-01	ANVSAnnovis Bio, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-02-06	NAVIDEA BIOPHARMACEUTICALS, INC.Stock OptionA Award	Director	AAward	+2,500 sh	$0.00	+$2.5	7,500
2020-02-06	NAVIDEA BIOPHARMACEUTICALS, INC.A Award	Director	AAward	+2,500 sh	$0.00	+$2.5	10,050
2020-01-31	ANVSAnnovis Bio, Inc. · Convertible NoteC Conversion	Director	CConversion	−1,117 sh	$4.80	−$5,361.6	0
2020-01-31	ANVSAnnovis Bio, Inc. · Series A-1 Preferred StockC Conversion	Director	CConversion	−5,556 sh	—	—	0
2020-01-31	ANVSAnnovis Bio, Inc.C Conversion	Director	CConversion	+1,117 sh	$4.80	+$5,361.6	5,886
2020-01-31	ANVSAnnovis Bio, Inc.C Conversion	Director	CConversion	+3,969 sh	—	—	4,769
2020-01-31	ANVSAnnovis Bio, Inc.P Purchase	Director	PPurchase	+800 sh	$6.00	+$4,800	800
2019-05-13	NAVIDEA BIOPHARMACEUTICALS, INC.P Purchase	Director	PPurchase	+2,550 sh	$1.90	+$4,855.2	7,550
2019-02-07	NAVIDEA BIOPHARMACEUTICALS, INC.A Award	Director	AAward	+50K sh	$0.00	+$50	100,000
2019-02-07	NAVIDEA BIOPHARMACEUTICALS, INC.Stock OptionA Award	Director	AAward	+50K sh	$0.00	+$50	100,000
2018-03-15	NAVIDEA BIOPHARMACEUTICALS, INC.Stock OptionA Award	Director	AAward	+50K sh	$0.00	+$50	50,000
2018-03-15	NAVIDEA BIOPHARMACEUTICALS, INC.A Award	Director	AAward	+50K sh	$0.00	+$50	50,000

Recent filings

Accepted (ET)
Nov 124
Bruck Claudine0001104659-25-109904
SEC(opens sec.gov)
Jul 34
Bruck Claudine0001104659-24-077831
SEC(opens sec.gov)
Nov 224/A
Bruck Claudine0001104659-23-120749
SEC(opens sec.gov)
Nov 214
Bruck Claudine0001104659-23-120299
SEC(opens sec.gov)
Apr 114
Bruck Claudine0001104659-23-044208
SEC(opens sec.gov)
Jan 204
Bruck Claudine0001104659-23-005475
SEC(opens sec.gov)
Jan 54
Bruck Claudine0001104659-22-001637
SEC(opens sec.gov)
Oct 134
Bruck Claudine0001415889-21-004864
SEC(opens sec.gov)
Jul 94
Bruck Claudine0001104659-21-090741
SEC(opens sec.gov)
Jul 74
Bruck Claudine0001437749-21-016596
SEC(opens sec.gov)
Jan 144
Bruck Claudine0001437749-21-000725
SEC(opens sec.gov)
Jul 64
Bruck Claudine0001104659-20-081248
SEC(opens sec.gov)
Feb 74
Bruck Claudine0001437749-20-002027
SEC(opens sec.gov)
Feb 54
Bruck Claudine0001104659-20-010940
SEC(opens sec.gov)

Companies

Address

C/O ANNOVIS BIO, INC. 101 LINDENWOOD DR, SUITE 225

MALVERN, PA, 19355